Associated Papers
Estimated global prevalence of genetic carriers of hereditary pheochromocytoma-paraganglioma syndrome in a large multiethnic genomic database.
Charoenngam N et al.
European Journal of Endocrinology, 2025
40974092 (PubMed )
Supplement: lvaf191_supplementary_data.docx
Succinate Dehydrogenase and Ribonucleic Acid Networks in Cancer and Other Diseases.
Moreno C et al.
Cancers, 2020
Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches.
Gieldon L et al.
Cancers, 2019
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma.
Richter S et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2019
30050099 (PubMed )
Supplement: NIHMS1505462-supplement-Supplementary_information_3.xlsx › SDHx_variants
The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).
Else T et al.
The Journal of Clinical Endocrinology and Metabolism, 2014
Structure, function, and assembly of heme centers in mitochondrial respiratory complexes.
Kim HJ et al.
Biochimica Et Biophysica Acta, 2012
Protein-mediated assembly of succinate dehydrogenase and its cofactors.
Van Vranken JG et al.
Critical Reviews in Biochemistry and Molecular Biology, 0
Select a paper to view details